Early bronchial hyperresponsiveness following injection of sephadex beads in the guinea pig: involvement of platelet activating factor and thromboxane A2.
The effects of an intravenous injection (i.v.) of Sephadex beads (20 mg kg(-1)) were examined on bronchial responsiveness to ACh (1-200 microg kg(-1) i.v.) as well as on cell accumulation in guinea-pig lung. Bronchial hyperreactivity to ACh, measured as increase in pulmonary insufflation pressure (PIP), was observed 3 h following the i.v. injection of Sephadex beads. However, no significant increase in bronchial reactivity to ACh was measured at 6 and 12 h following Sephadex injection. A second later increase in bronchial hyperresponsiveness was observed at 24 h. Bronchoalveolar lavage performed at 3 h following Sephadex treatment showed that there was no significant increase in total or differential cell number. At 6 h and 12 h, a significant increase in total cell counts was observed. At 24 h, a greater than 5-fold increase in cell number was observed and was related to a marked eosinophil, neutrophil and macrophage infiltration. A platelet-activating factor (PAF) antagonist, CV-3988 (10 mg kg(-1) i.v.), and a thromboxane A2 (TxA2) antagonist, L655,240 (10 mg kg(-1) i.v.), significantly attenuated the Sephadex-induced bronchial hyperresponsiveness to ACh observed at 3 h. The results show that an i.v. injection of Sephadex beads in guinea pigs can induce an early bronchial hyperresponsiveness to ACh that is mediated by the release of both PAF and TxA2 and is independent of airway cell infiltration.
Conroy
D M
DM
Institute of Pharmacology of Sherbrooke, Faculty of Medicine, University of Sherbrooke, PQ, Canada.
Sirois
P
P
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D016535:Bronchial Hyperreactivity / Q000139:chemically induced / Q000378:metabolism; D003911:Dextrans / Q000633:toxicity*; D006168:Guinea Pigs; D007202:Indicators and Reagents / Q000633:toxicity*; D010972:Platelet Activating Factor / Q000378:metabolism*; D013928:Thromboxane A2 / Q000378:metabolism*; D014665:Vasodilator Agents / Q000494:pharmacology
D003911:Dextrans; D007202:Indicators and Reagents; D010972:Platelet Activating Factor; D014665:Vasodilator Agents; D013928:Thromboxane A2; C025614:sephadex; D000109:Acetylcholine